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ABSTRACT 
 Aizoon canariense, Cynomorium coccineum, 
Glossonema edule, and Malva parviflora, edible 
desert plants from Qatar, were selected to deter-
mine levels of phenolic bioactives and potential 
health benefits for managing early stages of type 2 
diabetes and hypertension.  Aqueous extracts of C. 
cocineum, contained soluble phenolics and had 
relatively high levels of antioxidant activity associ-
ated with α-glucosidase, α-amylase, and angio-
tensin-converting enzyme (ACE).  G. edule and M. 
parviflora had moderate levels of anti-oxidant po-
tential, soluble phenolics, and ACE inhibitory 
activity.  The medicinal properties associated with 
C. coccineum suggest the plant may have potential 
as a diet-based solution for combating, preventing, 
and managing the early stage of type 2 diabetes 
when coupled with an overall healthy life style and 
pharmacological management strategies.   
 
INTRODUCTION 
 Type 2 diabetes mellitus is a systemic, multi-
layered chronic disease with worldwide impact, 
reaching epidemic proportions and projected to be the 
7th leading cause of death by 2030 (WHO, 2013). 
Qatar is predicted to have the highest number of 
diabetic patients in the near future, with a reported 
increase of 130% by the year 2030 (Mushlin et al., 
2012).  Due to genetic susceptibility, children that 
have one or two diabetic parents are two to four times 
higher risk for being diagnosed with type 2 diabetes 
(Harrison et al., 2003). Consanguinity, the incidence 
of which is the highest in the State of Qatar (51%), is 
frequently the cause of the prevalence of many 
genetic disorders and other inherited adult diseases, 
such as diabetes (Bener et al., 2013).  In recent years, 
many edible food, medicinal, and spice plants have 
been investigated for potential benefits in managing 
type 2 diabetes (Kaur et al., 2015; Mirmiran et al., 
2014).  
 Among the most important plant-based 
antioxidants are the dietary phenolics that are thought  
to be more effective as an antioxidants than vitamin E 
or C in vitro and in vivo (Rice-Evans et al., 1997) 
because they potentially have direct enzyme 
inhibitory benefits as targets for hyperglycemia and 
managing carbohydrate metabolism. Specifically, 
apart from the antioxidant properties, phenolic 
compounds are natural inhibitors of α-glucosidase 
and α-amylase enzymes applicable for the 
management of early stages of hyperglycaemia 
associated with type 2 diabetes.  
 A method available for the management of type 
2 diabetes is to impede the breakdown and intestinal 
absorption of glucose through the inhibition of 
pancreatic α-amylase and intestinal α-glucosidase 
enzymes (Pinto et al., 2009). The presence of the 
phenolics that act as α-glucosidase and α-amylase 
inhibitors in fruits, vegetables and spices could be a 
good approach to control post-prandial hyper-
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glycemia and provide effective benefits without side 
effects. Further, many plants are also reported to be 
anti-hypertensive mainly for their potential to inhibit 
angiotensin converting enzyme (ACE) (Castro et al., 
2000), which can be targeted for managing 
macrovascular complications of type 2 diabetes.  
 In the current study, phenolic bioactives from 
four traditional edible plants from Qatar were 
analysed for their potential in inhibiting α-
glucosidase, α-amylase and ACE using in vitro assay 
models.  In addition, the relevant total phenolic con-
tent, antioxidant potential and the different types of 
phenolic compounds and their content were analyzed 
using high performance liquid chromatography 
(HPLC).  The studied food plants were once a part of 
the diet of the local Qatari population, but have been 
largely replaced by imported provisions.  Establishing 
and incorporating the anti-diabetic potential of local 
food into diets could help in manage this disease. 
  
MATERIALS AND METHOD 
 Plant samples.  Indigenous plants, Cynomorium 
coccineum (local name: Trathuth), Aizoon canariense 
(local name: Jafna), Glossonema edule (local name: 
Yerawa), and Malva parviflora (local name: 
Khobeza) were collected locally and identified by a 
faculty member in the Department of Biological and 
Environ-mental Sciences, Qatar University, Doha. 
Porcine pancreatic α-amylase (EC 3.2.1.1), rat 
intestinal α–glucosidase (EC3.2.1.20), hippuric acid, 
rabbit lung ACE (angiotensin I-converting enzyme) 
(EC 3.4.15.1), 2,2-diphenyl-1-picrylhydrazyl (DPPH), 
acarbose, and ascorbic acid were purchased from 
Sigma Chemical Co.  Standards for gallic acid were 
also purchased from Sigma Chemical Co. 
 Sample extraction. The edible portions of the 
selected plants were extracted with water to deter-
mine the chemical constituency.  For A. canariense 
and M. parviflora, the entire plants were macerated 
before extraction.  For the C. coccineum, the inner 
flesh of the stem was removed and then extracted.  
The fruit of G. edule were cut into small pieces with a  
cheese grater and then uniformly mixed before 
extraction.  All samples (2.5 g) were extracted in 100 
mL of distilled water under reflux at 95oC for 30 min.  
Each of the samples was subsequently centrifuged at 
11,000 g for 10 min to separate cellular debris from 
the extract.   
 Soluble phenolics. Total soluble phenolics in 
each of the test samples were determined using a 
previously established assay (Kwon et al., 2006).  In 
brief, a 0.5 mL of sample extract was weighed and 
added to a test tube.  Each of the samples in the test 
tubes was subsequently mixed with 1 mL of 95% 
ethanol, 5.5 mL of distilled water, and 0.5 mL of 50% 
Folin-Ciocalteu reagent. After five minutes, 1 mL of 
5% sodium carbonate was added to stop the reaction  
and the absorbance of the mixture was determined at 
725 nm using a UV-visible light spectrophotometer 
(Agilent Model 8453) after a 1 h dark incubation.  
Gallic acid was used as a standard, and the results 
were expressed as µg gallic acid/mL of sample fresh 
weight.   
 Antioxidant activity. The antioxidant activity 
was determined using a DPPH radical scavenging 
method modified from Kwon et al. (2006).  A 250  
L aliquot of the sample extract was mixed with 1.25 
mL of DPPH (60 M in ethanol) and then centrifuged 
at 5000 g for one minute.  The absorbance was 
measured at 517 nm using the previously 
described Agilent UV-visible light spectrophotometer. 
The absorbance readings were compared with a 
control containing 95% ethanol in place of the sample 
extract. The inhibition was calculated as:  
        
 -Amylase inhibition. The -amylase inhibi-
tory activity was determined using a modified assay 
of that described in the Worthington Enzyme Manual 
(Worthington, 1993; Kwon et al., 2006).  A total of 
500 L of 0.02 M sodium phos-phate buffer (pH 6.9 
with 0.006 M NaCl) containing 0.5 mg/mL of -
amylase were pre-incubated at 25oC for 10 min.  
After the pre-incubation, 500 µL of a 1% starch 
solution in 0.02 M sodium phosphate buffer (pH 6.9 
with 0.006 M NaCl) was added to each tube at timed 
intervals. The reaction was stopped using 1.0 mL of 
dinitrosalicylic (DNS) acid color reagent.  The test 
tubes were incubated in a boiling water bath for 5 
min and then cooled to room temperature. The 
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reaction mixture was diluted by adding 5 to15 mL of 
distilled water, and the absorbance was measured at 
540 nm using the previously described UV-Visible 
light spectrophotometer. The absorbance readings 
were compared with the controls that contained 
buffer instead of sample extract.  The percentage -
amylase inhibitory activity was calculated using the 
same equation used for percentage inhibition in the 
DPPH radical inhibition assay. 
-Glucosidase.  Inhibitory activity of -
glucosidase was measured following a modified 
procedure described by McCue et al. (2005).  The -
glucosidase was assayed using 50 L of sample 
extracts and 100 L of 0.1 M phosphate buffer (pH 
6.9) containing -glucosidase solution (1 U/mL), 
which was then incubated in 96-well plates at 25°C 
for 10 min.  After the pre-incubation period, 50 L of 
5 mM p-nitrophenyl--d-glucopyranoside solution in 
0.1 M phosphate buffer (pH 6.9) was added to each 
well at timed intervals. The reaction mixtures were 
incubated at 25°C for 5 min.  
 Before and after incubation, absorbance 
readings of the samples were recorded at 405 nm 
using a microplate reader (Semi-Automated ELISA 
System, TECAN SUNRISE Reader, Model Sunrise, 
Austria) and compared with a control that had 50 L 
of buffer solution in place of the extract.  The -
glucosidase inhibitory activity was expressed as 
percent inhibition and was calculated using the same 
equation used for determining the percent inhibition 
in the DPPH radical inhibition assay.  Dose 
dependency was tested using 0.5 µL to 25 µL 
following the same protocol.    
ACE inhibition. ACE inhibition was assayed 
by a method modified by Kwon et al. (2006), using 
hippuryl-histidyl-leucine (HHL) as a substrate and 
the ACE-I enzyme from rabbit lung (EC 3.4.15.1).  A 
volume of 50 L of sample extracts was incubated 
with 100 L of 1 M NaCl-borate buffer (pH 8.3) 
containing 2 mU of ACE-I solution at 37°C for 10 
min.  After pre-incubation, 100 L of a 5 mU sub-
strate (HHL) solution was added to the reaction 
mixture.  Test solutions were incubated at 37°C for 1 
h.  The reaction was stopped with the addition of 150 
L of 0.5 N HCl to the reaction.   
A 5 L sample of the stopped reaction mixture 
was injected into a high-performance liquid chroma-
tography (HPLC) apparatus (Agilent 1100 with UV- 
Detector 1100, Autosampler 1200 & Column com-
partment 1200, Agilent Technologies, Palo Alto, 
CA). The solvents used for the gradient were 10 mM 
phosphoric acid (pH 2.5) and 100% methanol. The 
methanol concentration was 60% for the first 8 min 
and then increased to 100% for 5 min followed by a 
decrease to 0% for the next 5 min (total run time of 
18 min).  The analytical column was an Agilent 
Nucleosil 100-5C18, 250 mm x 4.6 mm inside 
diameter, filled with packing material of 5 m 
particle size, and used a flow rate of 1 mL/min at 
ambient temperature. During each run, the 
absorbance was recorded at 228 nm for the detection 
of liberated hippuric acid and retention time by 
comparison with a calibration standard of hippuric 
acid.  The percentage inhibition was calculated using 
a formula similar to that used for determining the 
inhibition of for antioxidant activity of α-amylase.  
 
HPLC analysis of phenolics.  For analysis of 
phenolics by HPLC, a 2 mL samples of the extracts 
were filtered (pore size, 0.2 μm), and 5 μL was 
injected into the HPLC apparatus (Agilent 1100 with 
UV-Detector  1100, Auto-sampler 1200 and Column 
compartment 1200, Agilent Technologies, Palo Alto, 
CA).  For gradient elution, the solvents were:  10 mM 
phosphoric acid (pH 2.5) and 100% methanol. The 
methanol concentration was increased from 0 to 60% 
for the first 8 min and to 100% over the next 7 min, 
then decreased to 0% for the next 3 min and 
maintained for the next 7 min (total run time of 25 
min).  
The analytical column, an Agilent Zorbax SB-
C18, 250 mm x 4.6 mm i.d. packed with 5 μm 
particle size, used a flow rate of 1 mL/min at ambient 
temperature.  Absorbance was recorded at 306 nm.  
Calibration standards were cinnamic acid, rosmarinic 
acid, protocatechuic acid, p-coumaric acid, 
chlorogenic acid, caffeic acid, ferulic acid, gallic 
acid and quercetin.  Extract constituents were 
identified by comparison of retention times and diode 
Phoboo et al.: In Vitro Assays of Anti-diabetic and Anti-hypertensive Potential
25 
 
array spectral characteristics with the standards. The 
results were expressed as L/g of sample fresh 
weight. 
Statistical analysis. Statistical analysis was a 
one-way analysis of the variance (ANOVA).  Post-
hoc comparisons were done using LSD test or a 
planned comparison in SPSS version 16.0. (p < 0.05). 
 
RESULTS AND DISCUSSION 
Antioxidant activity, soluble phenolics, and 
HPLC analysis. The total antioxidant activity and 
total soluble phenolics of all four edible plants of 
Qatar showed significantly different results (Figure 
1).   Cynomorium coccineum had significantly higher 
antioxidant activity and total soluble phenolics as 
comparison with the other three plants. Glossonema 
edule had high antioxidant activity, but moderate 
total soluble phenolics, whereas Malva parviflora and 
Aizoon canariense had low antioxidant activity and 
low total soluble phenolic content.  
Figure 1. Total soluble phenolics and DPPH inhibitory  
 potential of plants1. 
 
 
1Data are mean ± SE (n=9). Columns with different letters indicate   
statistically significant differences among groups at p<0.5. The 
Pearson’s correlation coefficient between total soluble phenolics 
and DPPH inhibitory potential was 0.79.  
 Among the studied edible plants, Cynomorium 
coccineum is of particular interest in for the medicinal 
applications in ancient times.  Zucca et al. (2013) 
evaluated both the aqueous and methanolic extracts 
of C. coccineum for total antioxidant capacity using 
selected ET-based methods, such as DPPH assay and 
ABTS-based assay  to measure the Trolox Equivalents 
Antioxidant Capacity (TEAC), and the FRAP method 
and ORAC assay based on pyrogallol red.  Significant 
antioxidant capacities using DPPH assay and ORAC-
PYR assays were observed.  Gao (2011) has reported 
that the extract of another species of Cynomorium, C. 
songaricum, contains proanthocyanidins that improve 
DPPH free-radical scavenging activity.   
 Jin et al. (2014) has noted that the antioxidant 
potential of acetone extract of C. songaricum, which 
contains catechins, is significantly superior anti-
oxidant activity compared with Vitamin E, but is 
inferior to ascorbic acid.  Nuo et al. (2010) has 
reported high DPPH and ABTS free-radical scaveng-
ing activity by C. songaricum polysaccharides.  Lu et 
al. (2004) investigated the antioxidant effects of 
aqueous extract C. songaricum in vitro on five types 
of edible oils, and reported that soybean oil possessed 
antioxidant capacity.  Zhao et al. (2009) has 
described the antioxidant capacity of phenolic 
compounds isolated from C. songaricum, which has a 
stronger antioxidant effect at a concentration of 
0.2596 mg/mL when compared with vitamin C. 
 In the current study, Malva parviflora had low 
DPPH inhibitory activity and low total soluble 
phenolics content. Although aqueous extracts were 
used, the results agreed with a report by Afolayan et 
al. (2008) indicating the methanolic extract of M. 
parviflora had 9.3% DPPH inhibition and the 
methanol extract inhibited 94.3% ABTS (2,2`-azinobis 
[3-ethylbenzothiazoline-6-sulfonic acid] diammonium 
salt) radical ion.  Farhan, et al. (2012) reported aque-
ous and ethanolic extracts at 4 mg/mL of crude leaves 
and stems of M. parviflora grown in Lebanon have 
high DPPH inhibitory activity, enhancing the scav-
enging activity by 59% and 70%, respectively. The 
current study, however, does not support the findings 
of Farhan et al. (2012), but this could be due to 
differences in extraction methods, genetic variation in 
the edible plants, growing conditions, or assay 
methodology.  
 The investigation of hydroxycinnamic acids 
and other phenolic acids has not previously been 
investigated in the four species of plants studied in 
this report.  Using HPLC chromatography, the current 
Phoboo et al.: In Vitro Assays of Anti-diabetic and Anti-hypertensive Potential
26 
 
study demonstrated the presence of various phenolic 
acids, such as gallic acid, chlorogenic acid, caffeic 
acid, protocatechuic acid, and cinnamic acid, along 
with quercetin in all four edible Qatari plant samples  
 
                   Table 1. Phenolic compounds in aqueous extracts of plants. 
Phytochemical Cynomorium 
coccineum 
Malva 
parviflora 
Aizoon 
canariense 
Glossonema 
edule 
-------------------- (L /L) -------------------1,2 
Gallic acid 8.12 ± 0.29a 1.61 ± 0.42bc 2.30 ± 0.59b 0.67 ± 0.23c 
Chlorogenic acid 5.56 ± 0.29a 2,18 ± 0.14b 2.47 ± 0.27b 0.49 ± 0.12c 
Caffeic acid 0.94 ± 0.17a 0.80 ± 0.10a 2,23 ± 0.46b 0.49 ± 0.11a 
Protocatechuic acid 3.51 ± 0.66ac 2.50 ± 0.51ab 5.42 ± 1.09c 0.77 ± 0.29b 
Cinnamic acid 5.95 ± 0.95a 3.54 ± 0.60a 4.28 ± 0.71a 0.01 ± 0.01b 
Quercetin 1.51 ± 0.42a 4.13 ± 0.55b ------ 2.08 ± 0.45ab 
                      1Means ± standard error, n=9.  
                     2Means with different letters within rows are significantly different, p<0.05..
 Cynomorium coccineum, in general, had higher 
amounts of the phenolic phytochemicals. The gallic 
acid content (8.12 L/L) was highest in C. 
coccineum, whereas quercetin content was highest in 
Malva parviflora (4.13 L/L).  Protocatechuic acid 
and cinnamic acid content were highest in Aizoon 
canariense at 5.42 L/L and 5.95 L/L, respectively. 
Zucca et al. (2013) also has reported the presence of 
gallic acid in the extracts of C. coccineum.  Rizk et al. 
(1990) reported the presence of flavonoids, mainly 
apigenin, 6,8 di-C-glucoside, and luteolin 7-O- 
glucoside, in unripe fruit of Glossonema edule, 
whereas A. canariense has been reported to contain 
alkaloids, coumarins, saponins, tannins, flavonoids, 
steroids, and triterpenes.  In a study by Farhan et al. 
(2012) the methanolic fractions of polyphenols from 
leaves and stems of M. parviflora contained different 
amounts of phenolic compounds, flavonoids, 
saponins, alkaloids, resins and tannins.  
 -Glucosidase/amylase inhibition. Based on 
the in vitro assay model, only Cynomorium 
coccineum extracts inhibited α-glucosidase and α-
amylase enzymes.  Aqueous extract of C. coccineum 
demonstrated a relatively high α-glucosidase inhibi-
tory activity (Table 2).  In contrast, a moderate 
inhibition of α-amylase was observed in the aqueous 
extracts of C. coccineum where 300 µL of extract 
caused a 54.4% inhibition (Fig. 2).  -Amylase and 
α-glucosidase are key enzymes involved in starch 
breakdown and subsequent glucose release leading to 
rapid intestinal absorption.  When inhibited by a high 
carbohydrate diet, these enzymes are beneficial in 
maintaining the postprandial blood sugar level and 
managing hyperglycemia (Puls et al., 1977).  A major 
drawback of currently used -glucosidase and -
amylase inhibitors, such as pharmacologically 
beneficial acarbose, are side effects, such as 
abdominal distention, flatulence, tympanitis, and 
diarrhea.  These side effects are possibly due to 
complete inhibition of -amylase, leaving the 
carbohydrate to ferment in the colon (Bischoff et al., 
1985; Bischoff, 1994). 
        Table 2. α-Glucosidase inhibitory potential  
                     of C. coccineum aqueous extract. 
Doses   Inhibition (%) ±SE 
10 µl 96.02 ± 0.05 
15 µl 96.92 ± 0.21 
20 µl 95.75 ± 0.06 
25 µl 96.13 ± 0.15 
30 µl 95.89 ± 0.07 
35 µl 95.81 ±0.25 
40 µl 95.46 ±0.10 
50 µl 95.53 ± 0.21 
 Thus, integrating natural inhibitors from dietary 
edible plants with lower inhibitory effects against α-
amylase activity and a stronger inhibitory activity 
against α-glucosidase can be potentially targeted as a 
more complimentary and effective therapy for 
postprandial hyperglycemia control with minimal 
side effects (Kwon et al. 2006).  The result of this in 
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vitro study indicates a biochemical rationale for why 
C.  coccineum has the potential to be highly effective 
in modulating sugar uptake with a potentially 
moderate effect on rapid starch break-down. 
 
     Data are mean % ± SE values (n=9).   a-dColumns 
      with different letters indicate statistically significant 
       differences among groups at p < 0.05. 
 ACE inhibition assay. In an in vitro assay, the 
aqueous extracts from Cynomorium coccineum, 
Glossonema edule, and Malva parviflora inhibited 
ACE inhibitory activity, but the aqueous extracts of 
Aizoon canariense did not inhibit ACE.  Of the three 
studied plants, an aqueous extract of C. coccineum 
had a higher ACE inhibitory action, 38.46 ± 3.38%, 
than Glossonema edule, 27.81 ± 0.96% inhibition, 
and Malva parviflora, 11.12 ± 6.06 % inhibition. The 
long-term, macrovascular complications of diabetes 
is hypertension.  ACE is an important enzyme in 
maintaining vascular tension through the activation of 
and conversion of histidyl-leucine dipeptide to 
angiotensin II, a vasoconstrictor (Skeggs et al. 1956). 
 Angiotensin II leads to stimulated synthesis and 
release of aldosterone, increasing blood pressure by 
retaining sodium in the distal tubules (Lieberman 
1975). Inhibiting ACE is considered a beneficial 
therapeutic approach in the treatment of high blood 
pressure in both diabetic and non-diabetic patients.  
 
CONCLUSIONS 
The current study indicates a strong possibility 
that Cynomorium coccineum, an edible spice and 
food plant used in Qatar, could help manage glucose 
and glucose-induced high levels of reactive oxygen 
species (ROS) linked to hyperglycemia and type 2 
diabetes-associated hypertension.  To our knowledge, 
studies on anti-diabetic potential of Cynomorium 
coccineum, Aizoon canariense, and Glossonema 
edule have not previously been studied. 
Cynomorium coccineum which grows 
throughout the Mediterranean region, including North 
Africa, the Arab peninsula, and beyond, is an edible 
food and medicinal plant, commonly eaten during 
famines and prized for medicinal properties.  The 
high antioxidant potential, indicated by the strong 
DPPH inhibitory potential, plus the total soluble 
phenolics, potent α-glucosidase inhibition, moderate 
α-amylase inhibition, and ACE inhibiting potential, 
indicate that Cynomorium coccineum can be used as 
an edible source for preventing and managing the 
early stages of type 2 diabetes.  The -glucoside 
inhibitory activity in the extract of Cynomorium 
coccineum suggest that further investigation of this 
activity will be worthwhile, including a comparative 
study with acarbose, the α-glucosidase inhibitory 
clinical drug.  
 The moderate antioxidant potential and total 
soluble phenolics and ACE inhibitory potential 
demonstrated by Malva parviflora and Glossonema 
edule may also be useful for potentially managing 
hypertension and oxidation-linked vascular compli-
cations.  Indeed, additional studies may validate the 
biochemical rationale of traditional edible food plants 
and overall health benefits of plants that were 
historically an important part of the Qatari diet.  
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